JNCCN-360

Editor:

Karl D. Lewis, MD

Advertisement

Advertisement

Eric Roeland, MD, on Prophylactic Strategies for Highly Emetogenic Chemotherapy

Kim A. Margolin, MD, on the Emerging Role of Medical Oncologists in Treating Non-Melanoma Skin Cancers

Charles von Gunten, MD, PhD, on Opioids for Managing Cancer Pain

Recent

2019 AAD: Using Artificial Intelligence to Diagnose Skin Cancers

Skin Cancer Among Childhood Cancer Survivors

FDA Proposes Updated Requirements for Sunscreen Products

Skin Cancer Incidence in Patients Receiving Multiple Kidney Transplants

Published

Medical Literature

Use of Pembrolizumab in First-Line Treatment of Merkel Cell Carcinoma

Comparing Staging Systems in Cutaneous Squamous Cell Carcinoma

Impact of HLA Antigen Mismatches on Skin Cancer Risk in Transplant Recipients

Use of Cetuximab in Multimodality Treatment of Cutaneous Squamous Cell Carcinoma

Ongoing

Dermatologic Oncology Update: Conversations with Oncology Investigators Bridging the Gap between Research and Patient Care

The Evolving Role of Biomarkers in Oncology

PD-L1 Expression Testing

Immunotherapy for cSCC: How, Why, and When (login required)

Available

Clinical Trials

Fox Chase Cancer Center

Helen Diller Family Comprehensive Cancer Center

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Stanford Cancer Institute

Sections

NCCN Resources

Copyright © 2019 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.